The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression-Reference-Cited by-同舟云学术

The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression

Published:2014-06 Issue:3 Volume:34 Page:337-343
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Lee Sheng-Yu,Chen Shiou-Lan,Chang Yun-Hsuan,Chen Po See,Huang San-Yuan,Tzeng Nian-Sheng,Wang Yu-Shan,Wang Liang-Jen,Lee I Hui,Wang Tzu-Yun,Yeh Tzung Lieh,Yang Yen Kuang,Hong Jau-Shyong,Lu Ru-Band

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference58 articles.

1. Recurrence of bipolar disorders and major depression. A life-long perspective.;Angst;Eur Arch Psychiatry Clin Neurosci,2003

2. Bipolar II depression in late life: prevalence and clinical features in 525 depressed outpatients.;Benazzi;J Affect Disord,2001

3. Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania.;Benazzi;J Affect Disord,2003

4. The bipolar spectrum.;Angst;Br J Psychiatry,2007

5. Bad medicine: bipolar II disorder.;Spence;BMJ,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

2. Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis;Frontiers in Psychiatry;2024-01-30

3. The role of NMDA receptors in bipolar disorder: A systematic review;Bipolar Disorders;2023-05-19

4. The Early-Onset Efficacy of Memantine Adjunctive Treatment for Depressive Symptoms: A Systematic Review and Updated Meta-Analysis;2023

5. The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: A systematic review and updated meta-analysis of double-blind randomized controlled trials;Journal of Affective Disorders;2022-06